Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomics.
Saved in:
| Title: | Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomics. |
|---|---|
| Authors: | Chayen B; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Dinstag G; Pangea Biomed Ltd., Tel-Aviv, Israel., Tirosh O; Pangea Biomed Ltd., Tel-Aviv, Israel., Gugel L; Pangea Biomed Ltd., Tel-Aviv, Israel., Beker T; Pangea Biomed Ltd., Tel-Aviv, Israel., Gottlieb T; Pangea Biomed Ltd., Tel-Aviv, Israel., Elia A; Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Pikarsky E; Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; The Lautenberg Center for Immunology, IMRIC, the Hebrew University of Jerusalem, Jerusalem, Israel., Lotem M; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; The Lautenberg Center for Immunology, IMRIC, the Hebrew University of Jerusalem, Jerusalem, Israel., Avner M; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; The Hadassah Cancer Research Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Cohen JE; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; The Hadassah Cancer Research Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Aharonov R; Pangea Biomed Ltd., Tel-Aviv, Israel., Popovtzer A; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; The Hadassah Cancer Research Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Arnon J; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; The Hadassah Cancer Research Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 13; Vol. 17, pp. 1822422. Date of Electronic Publication: 2026 May 13 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1822422 |
